Complement, pre-activation |
C3 (human) (Janssen et al. 2005) |
2A73 |
C3 (bovine) (Fredslund et al. 2006) |
2B39 |
C4 (Kidmose et al. 2012) |
4FXK,4FXG |
C5 (Fredslund et al. 2008) |
3CU7 |
C5-SSL7 (Laursen et al. 2010) |
3KLS,3KM9 |
C5-CVF (Laursen et al. 2010) |
3PVM,3PRX |
Complement, post-activation |
C3b (Janssen et al. 2006) |
2I07 |
C3b-CR1g (Wiesmann et al. 2006) |
2ICF |
C3b-fH (Wu et al. 2009) |
2WII |
C3bBb (Forneris et al. 2010) |
2XWJ |
C3bBbD (Forneris et al. 2010) |
2XWB |
C3c (Janssen et al. 2005) |
2A74 |
C3c-CR1g (Wiesmann et al. 2006) |
2ICF |
C3d (Nagar et al. 1998) |
1C3D |
C3d-CR2 (Szakonyi et al. 2001; van den Elsen and Isenman 2011) |
1GHQ,3OED |
C5b6 (Hadders et al. 2012) |
4A5W |
A2M structures |
A2M MG2 (Doan and Gettins 2007) |
2P9R |
A2M RBD (human) (Jenner et al. 1998) |
1AYO |
A1M RBD (rat) (Xiao et al. 2000) |
1EDY |
A2M(MeNH2) (Marrero et al. 2012) |
4ACQ |
iTEP structures |
AgTEP1*R1 (Baxter et al. 2007) |
4D94 |
AgTEP1*S1 (Le et al. 2012) |
4LNV |